Pharma Tips

Strides gets FDA approval to market skin disease drug in US

By: Pharma News | Views: 1139 | Date: 05-Jul-2014

Strides Arcolab has received regulatory approval to market a skin disease drug in the US.The US Food and Drug Administration (FDA) has allowed the company to sell Methoxsalen capsules of 10 mg strength, Bangalore-based Strides Arcolab said in a statement

Strides gets FDA approval to market skin disease drug in US, stock closes 9.54% higher


Strides gets FDA approval to market skin disease drug in US, stock closes 9.54% higher


Strides Arcolab has received regulatory approval to market a skin disease drug in the US.

The US Food and Drug Administration (FDA) has allowed the company to sell Methoxsalen capsules of 10 mg strength, Bangalore-based Strides Arcolab said in a statement.

The US market for generic Methoxsalen capsules is pegged at about $13.6 million, with no generic player, the company said, citing IMS data.

"The product will be manufactured at the company's FDA-approved oral dosage facility in Bangalore and marketed directly by Strides in the US," the company said.

Methoxsalen is used to treat psoriasis, eczema, vitiligo and some cutaneous lymphomas in conjunction with exposing the skin to UVA light from lamps or sunlight. It modifies the way skin cells receive UVA radiation, clearing up the disease.

Strides Arcolab shares closed 9.54 per cent higher at Rs 599.70 on the BSE.

Previous Page Next Page

People Searching On This Page:
  • when the drug methoxsalen is introduced to.market

Related Pages


FDA hikes fee for drug approvals, cuts unit inspection charge

FDA hikes fee for drug approvals, cuts unit inspection charge

News | FDA
Date:
08-Aug-2015  Views: 1661

US regulator FDA has hiked its fees for new generic drug applications by up to 30 per cent, a move that may hit hard Indian drug makers, which account ...
New & Generic Drug Approvals by US FDA -2014

New & Generic Drug Approvals by US FDA -2014

News | FDA
Date:
23-Sep-2014  Views: 2257

...
Zydus Cadila Gets USFDA Nod for Kidney Stones Tablets

Zydus Cadila Gets USFDA Nod for Kidney Stones Tablets

News | FDA
Date:
14-Aug-2014  Views: 1545

Drug firm Zydus Cadila has received the final approval from the US health regulator to market Potassium Citrate ER tablets used in prevention of kidne ...
Ranbaxy gets FDA approval to sell generic Diovan tablets in US

Ranbaxy gets FDA approval to sell generic Diovan tablets in US

News | FDA
Date:
27-Jun-2014  Views: 1516

Drug major Ranbaxy Laboratories has received US health regulator's approval to market generic version of Novartis' Diovan tablets, used for treating h ...
Glenmark gets USFDA nod for alcohol abstinence drug

Glenmark gets USFDA nod for alcohol abstinence drug

News | FDA
Date:
14-Aug-2013  Views: 8289

Glenmark Pharmaceuticals today said it has received US health regulator's approval to market generic version of Forest Laboratories' Campral Delayed R ...
Post Your Comments (No Login Require)
Name : (required)
Email : (required)
Website :

Comment : (required)

50  + 3 =     
Comments
People Searched About:
When The Drug Methoxsalen Is Introduced To.Market   |  
Google : 34 times | Yahoo : 50 times | Bing : 14 times |